Data by Company within Biotechnology & Pharmaceuticals Industry
|
|
Marketcap |
Revenues (TTM) |
Net Income (TTM) |
Employees |
Company |
(Millions) |
(Millions) |
(Millions) |
Number |
Amgen Inc |
$ 145,687 |
$ 28,190 |
$ 6,717 |
24,200 |
Gilead Sciences Inc |
$ 92,226 |
$ 27,116 |
$ 5,613 |
14,400 |
Seagen Inc |
$ 43,034 |
$ 2,300 |
$ -750 |
2,700 |
Moderna Inc |
$ 39,704 |
$ 6,848 |
$ -4,714 |
2,700 |
Biogen Inc |
$ 31,963 |
$ 9,836 |
$ 1,162 |
9,610 |
Argenx se |
$ 19,661 |
$ 856 |
$ -710 |
- |
Neurocrine Biosciences Inc |
$ 14,062 |
$ 1,887 |
$ 250 |
1,000 |
Bio techne Corp |
$ 11,608 |
$ 1,143 |
$ 224 |
3,000 |
Repligen Corp |
$ 10,786 |
$ 670 |
$ 116 |
1,170 |
Qiagen N v |
$ 10,156 |
$ 1,901 |
$ 341 |
5,700 |
Exelixis Inc |
$ 7,345 |
$ 1,830 |
$ 465 |
566 |
Vaxcyte Inc |
$ 7,086 |
- |
$ -300 |
- |
Crispr Therapeutics Ag |
$ 5,793 |
$ 170 |
$ -354 |
- |
Abcam Plc |
$ 5,511 |
- |
$ 0 |
- |
Halozyme Therapeutics Inc |
$ 5,479 |
$ 829 |
$ 282 |
3,011 |
Krystal Biotech Inc |
$ 4,849 |
- |
$ 11 |
- |
Immunovant Inc |
$ 4,412 |
- |
$ -243 |
- |
Orchard Therapeutics Plc |
$ 3,814 |
$ 22 |
$ -73 |
- |
Revolution Medicines Inc |
$ 3,477 |
$ 30 |
$ -331 |
- |
Arcellx Inc |
$ 3,421 |
- |
$ -130 |
- |
Iovance Biotherapeutics Inc |
$ 3,268 |
- |
$ -444 |
- |
Springworks Therapeutics Inc |
$ 3,174 |
- |
$ -348 |
- |
Immunocore Holdings Plc |
$ 2,976 |
- |
$ 0 |
- |
Apogee Therapeutics inc |
$ 2,817 |
- |
$ 0 |
- |
Beam Therapeutics Inc |
$ 2,798 |
$ 82 |
$ -314 |
- |
Denali Therapeutics Inc |
$ 2,758 |
$ 341 |
$ 0 |
340 |
Jasper Therapeutics Inc |
$ 2,752 |
- |
$ -61 |
- |
Immunitybio inc |
$ 2,557 |
$ 1 |
$ -459 |
- |
Recursion Pharmaceuticals Inc |
$ 2,330 |
$ 45 |
$ -328 |
- |
Outlook Therapeutics Inc |
$ 2,145 |
- |
$ -51 |
- |
Ginkgo Bioworks Holdings Inc |
$ 2,107 |
$ 315 |
$ -855 |
- |
Kymera Therapeutics Inc |
$ 2,096 |
$ 67 |
$ -103 |
- |
Vericel Corporation |
$ 2,012 |
$ 198 |
$ -3 |
- |
Twist Bioscience Corporation |
$ 1,934 |
$ 262 |
$ -206 |
750 |
Adaptimmune Therapeutics Plc |
$ 1,873 |
$ 66 |
$ -114 |
- |
Mesoblast Ltd |
$ 1,796 |
$ 8 |
$ -82 |
- |
Sana Biotechnology Inc |
$ 1,780 |
- |
$ -280 |
- |
Ambrx Biopharma Inc |
$ 1,743 |
$ 9 |
$ -134 |
- |
Inhibrx Inc |
$ 1,650 |
$ 2 |
$ -241 |
- |
Instil Bio Inc |
$ 1,614 |
$ 1 |
$ -197 |
- |
Opthea Limited |
$ 1,527 |
$ 0 |
$ -143 |
- |
Vir Biotechnology Inc |
$ 1,442 |
$ 86 |
$ -615 |
- |
4d Molecular Therapeutics Inc |
$ 1,332 |
$ 22 |
$ -96 |
- |
Adma Biologics Inc |
$ 1,301 |
$ 258 |
$ -28 |
256 |
Precision Biosciences Inc |
$ 1,298 |
$ 52 |
$ -74 |
- |
Scholar Rock Holding Corp |
$ 1,165 |
$ 47 |
$ -159 |
- |
Autolus Therapeutics Plc |
$ 1,013 |
$ 0 |
$ -149 |
- |
Curis Inc |
$ 996 |
$ 10 |
$ -47 |
- |
Regenxbio Inc |
$ 974 |
$ 99 |
$ -261 |
300 |
Relay Therapeutics Inc |
$ 972 |
$ 26 |
$ -327 |
- |
Biocryst Pharmaceuticals Inc |
$ 960 |
$ 331 |
$ -227 |
192 |
Tarsus Pharmaceuticals Inc |
$ 929 |
$ 17 |
$ -136 |
- |
Valneva Se |
$ 891 |
$ 390 |
$ -82 |
550 |
Cabaletta Bio Inc |
$ 833 |
- |
$ -62 |
- |
Icosavax Inc |
$ 766 |
$ 1 |
$ -97 |
- |
Vectivbio Holding Ag |
$ 745 |
$ 27 |
$ -94 |
- |
Fate Therapeutics Inc |
$ 738 |
$ 106 |
$ -173 |
208 |
Aerie Pharmaceuticals Inc |
$ 729 |
$ 214 |
$ -37 |
259 |
Neumora Therapeutics Inc |
$ 705 |
- |
$ 0 |
- |
Hillevax Inc |
$ 703 |
- |
$ -108 |
- |
Fusion Pharmaceuticals Inc |
$ 690 |
$ 2 |
$ 84 |
- |
Cullinan Oncology Inc |
$ 681 |
- |
$ -157 |
2 |
Tscan Therapeutics Inc |
$ 675 |
$ 17 |
$ -88 |
- |
Allogene Therapeutics inc |
$ 667 |
$ 0 |
$ -340 |
- |
Prime Medicine Inc |
$ 651 |
- |
$ 0 |
- |
Editas Medicine Inc |
$ 617 |
$ 78 |
$ -153 |
- |
Replimune Group Inc |
$ 568 |
- |
$ -210 |
- |
Novavax inc |
$ 533 |
$ 984 |
$ -545 |
370 |
Alector Inc |
$ 514 |
$ 96 |
$ -141 |
155 |
Mymetics Corporation |
$ 486 |
$ 1 |
$ -14 |
- |
Adaptive Biotechnologies Corporation |
$ 469 |
$ 180 |
$ -196 |
645 |
C4 Therapeutics Inc |
$ 443 |
$ 21 |
$ -132 |
- |
Voyager Therapeutics Inc |
$ 413 |
$ 250 |
$ 132 |
- |
Caribou Biosciences Inc |
$ 397 |
$ 34 |
$ -102 |
- |
Invivyd Inc |
$ 395 |
- |
$ -170 |
- |
Surrozen Inc |
$ 390 |
- |
$ -35 |
- |
Iteos Therapeutics Inc |
$ 387 |
$ 128 |
$ -62 |
97 |
Freeline Therapeutics Holdings Plc |
$ 384 |
- |
$ -140 |
- |
Tenaya Therapeutics Inc |
$ 368 |
- |
$ -128 |
- |
Meiragtx Holdings Plc |
$ 358 |
$ 14 |
$ -84 |
- |
Humacyte Inc |
$ 335 |
- |
$ -89 |
- |
Monte Rosa Therapeutics Inc |
$ 319 |
- |
$ -133 |
- |
Kodiak Sciences Inc |
$ 307 |
- |
$ -271 |
- |
Century Therapeutics inc |
$ 301 |
$ 2 |
$ -137 |
- |
Oyster Point Pharma Inc |
$ 300 |
$ 20 |
$ -235 |
- |
Poseida Therapeutics Inc |
$ 296 |
$ 52 |
$ -132 |
- |
Compass Therapeutics Inc |
$ 292 |
- |
$ -41 |
- |
Sab Biotherapeutics Inc |
$ 289 |
$ 4 |
$ -27 |
- |
Taysha Gene Therapies Inc |
$ 289 |
$ 14 |
$ -215 |
- |
Sophia Genetics Sa |
$ 289 |
$ 62 |
$ -79 |
- |
Ocugen Inc |
$ 277 |
- |
$ -76 |
- |
Aura Biosciences Inc |
$ 275 |
- |
$ -71 |
- |
Gritstone Bio Inc |
$ 275 |
$ 10 |
$ -71 |
- |
Solid Biosciences Inc |
$ 262 |
$ 15 |
$ -91 |
- |
Sutro Biopharma Inc |
$ 249 |
$ 49 |
$ -172 |
- |
Compugen Ltd |
$ 236 |
$ 8 |
$ -34 |
- |
Eiger Biopharmaceuticals Inc |
$ 228 |
$ 15 |
$ -87 |
- |
Checkmate Pharmaceuticals Inc |
$ 227 |
- |
$ -63 |
- |
Acumen Pharmaceuticals Inc |
$ 227 |
- |
$ -49 |
- |
Lineage Cell Therapeutics Inc |
$ 226 |
$ 9 |
$ -23 |
- |
Cardiff Oncology inc |
$ 225 |
$ 3 |
$ -23 |
- |
Agenus Inc |
$ 210 |
$ 101 |
$ -283 |
- |
Black Diamond Therapeutics Inc |
$ 210 |
- |
$ -82 |
- |
Coherus Biosciences inc |
$ 209 |
$ 257 |
$ -238 |
650 |
Innate Pharma Sa |
$ 201 |
$ 65 |
$ -65 |
- |
Omega Therapeutics Inc |
$ 200 |
$ 3 |
$ -108 |
- |
La Jolla Pharmaceutical Company |
$ 200 |
$ 46 |
$ 4 |
- |
Inmune Bio Inc |
$ 199 |
$ 0 |
$ -27 |
- |
Scilex Holding Company |
$ 192 |
$ 71 |
$ -117 |
- |
Graphite Bio Inc |
$ 191 |
- |
$ -126 |
- |
Tourmaline Bio Inc |
$ 185 |
- |
$ -63 |
- |
X4 Pharmaceuticals Inc |
$ 183 |
- |
$ -111 |
- |
Apeiron Capital Investment Corp |
$ 180 |
- |
$ 7 |
- |
Genfit S a |
$ 174 |
$ 30 |
$ -27 |
194 |
Adverum Biotechnologies Inc |
$ 172 |
$ 2 |
$ -126 |
- |
Xtant Medical Holdings Inc |
$ 157 |
$ 77 |
$ 3 |
- |
Vaxart Inc |
$ 156 |
$ 7 |
$ -82 |
- |
Bluebird Bio Inc |
$ 155 |
$ 22 |
$ -91 |
- |
Elevation Oncology inc |
$ 150 |
- |
$ -46 |
- |
Zura Bio Limited |
$ 150 |
- |
$ -61 |
- |
Titan Pharmaceuticals Inc |
$ 139 |
$ 2 |
$ -6 |
- |
Sangamo Therapeutics Inc |
$ 136 |
$ 176 |
$ -258 |
411 |
Vor Biopharma Inc |
$ 130 |
- |
$ -116 |
- |
Vigil Neuroscience Inc |
$ 130 |
- |
$ -79 |
- |
Armata Pharmaceuticals Inc |
$ 130 |
$ 4 |
$ -60 |
- |
Molecular Partners Ag |
$ 130 |
$ 7 |
$ -62 |
- |
Protalix Biotherapeutics inc |
$ 123 |
$ 65 |
$ 8 |
- |
Bioatla Inc |
$ 117 |
- |
$ -124 |
- |
Atyr Pharma Inc |
$ 113 |
$ 10 |
$ -43 |
- |
Athira Pharma Inc |
$ 100 |
- |
$ -121 |
- |
Cel sci Corporation |
$ 97 |
- |
$ -31 |
- |
Jounce Therapeutics inc |
$ 97 |
$ 148 |
$ 0 |
125 |
Cardiol Therapeutics inc |
$ 95 |
- |
$ 0 |
- |
Miromatrix Medical inc |
$ 93 |
$ 1 |
$ -32 |
- |
Allovir Inc |
$ 89 |
- |
$ -169 |
- |
Prokidney Corp |
$ 87 |
- |
$ -222 |
- |
Zivo Bioscience Inc |
$ 84 |
- |
$ -8 |
2 |
Passage Bio inc |
$ 82 |
- |
$ -102 |
- |
Dbv Technologies S a |
$ 76 |
$ 16 |
$ -73 |
- |
Champions Oncology Inc |
$ 74 |
$ 49 |
$ -10 |
- |
Genenta Science S p a |
$ 71 |
- |
$ -9 |
- |
Evaxion Biotech A |
$ 71 |
- |
$ -23 |
- |
Logicbio Therapeutics Inc |
$ 68 |
$ 11 |
$ -27 |
- |
Ikena Oncology Inc |
$ 68 |
$ 14 |
$ -63 |
- |
Atara Biotherapeutics Inc |
$ 66 |
$ 14 |
$ -290 |
- |
Intensity Therapeutics Inc |
$ 66 |
- |
$ 0 |
- |
Phoenix Biotech Acquisition Corp |
$ 65 |
- |
$ -3 |
- |
Surface Oncology Inc |
$ 65 |
$ 31 |
$ -93 |
- |
Semper Paratus Acquisition Corporation |
$ 63 |
- |
$ 4 |
- |
Tcr2 Therapeutics Inc |
$ 62 |
- |
$ -163 |
- |
Cidara Therapeutics Inc |
$ 62 |
$ 41 |
$ -28 |
- |
Elutia inc |
$ 60 |
$ 35 |
$ -38 |
- |
Redwoods Acquisition Corp |
$ 58 |
- |
$ 5 |
- |
Avrobio Inc |
$ 58 |
- |
$ -4 |
- |
Turnstone Biologics Corp |
$ 58 |
- |
$ 0 |
- |
Renovacor Inc |
$ 56 |
- |
$ -4 |
- |
Cognition Therapeutics inc |
$ 55 |
- |
$ -23 |
- |
Greenlight Biosciences Holdings Pbc |
$ 45 |
$ 10 |
$ -157 |
- |
Candel Therapeutics Inc |
$ 43 |
$ 0 |
$ -32 |
- |
Dyadic International Inc |
$ 43 |
- |
$ 2,482 |
84 |
Achilles Therapeutics Plc |
$ 43 |
- |
$ -71 |
- |
Protara Therapeutics Inc |
$ 42 |
- |
$ -69 |
- |
Pluri Inc |
$ 41 |
$ 0 |
$ -24 |
- |
Aligos Therapeutics Inc |
$ 40 |
$ 16 |
$ -82 |
- |
Gamida Cell Ltd |
$ 40 |
- |
$ 79 |
- |
Entera Bio Ltd |
$ 39 |
- |
$ 9 |
- |
Estrella Immunopharma Inc |
$ 39 |
- |
$ -4 |
- |
In8bio Inc |
$ 36 |
- |
$ -30 |
- |
Mink Therapeutics Inc |
$ 31 |
- |
$ -25 |
- |
Axcella Health Inc |
$ 30 |
- |
$ -48 |
- |
Cyclo Therapeutics Inc |
$ 27 |
$ 1 |
$ -20 |
- |
Nkgen Biotech Inc |
$ 26 |
- |
$ -38 |
- |
Applied Genetic Technologies Corporation |
$ 26 |
$ 42 |
$ -70 |
- |
Lexeo Therapeutics Inc |
$ 25 |
- |
$ 0 |
- |
Cargo Therapeutics Inc |
$ 23 |
- |
$ 0 |
- |
Erytech Pharma S a |
$ 18 |
- |
$ -60 |
- |
Pharmacyte Biotech Inc |
$ 17 |
- |
$ -2 |
- |
Senti Biosciences Inc |
$ 17 |
$ 4 |
$ -82 |
- |
Aim Immunotech Inc |
$ 16 |
- |
$ -22 |
- |
Acorda Therapeutics Inc |
$ 15 |
$ 111 |
$ -16 |
327 |
Brainstorm Cell Therapeutics inc |
$ 15 |
- |
$ -17 |
- |
Tracon Pharmaceuticals Inc |
$ 14 |
$ 11 |
$ -11 |
- |
Green Planet Bioengineering Co Ltd |
$ 12 |
- |
$ 0 |
- |
Inhibikase Therapeutics Inc |
$ 11 |
$ 0 |
$ -19 |
- |
Sorrento Therapeutics Inc |
$ 10 |
- |
$ 0 |
- |
Aptose Biosciences Inc |
$ 10 |
- |
$ -49 |
- |
Organovo Holdings Inc |
$ 9 |
$ 0 |
$ -19 |
- |
Biocardia Inc |
$ 8 |
$ 1 |
$ -13 |
- |
Old Ayala Inc |
$ 8 |
$ 1 |
$ -38 |
- |
Creative Medical Technology Holdings Inc |
$ 8 |
$ 0 |
$ -10 |
- |
Allena Pharmaceuticals Inc. |
$ 8 |
- |
$ -43 |
- |
Enzon Pharmaceuticals inc |
$ 6 |
$ 2 |
$ 1 |
- |
Rubius Therapeutics Inc |
$ 5 |
- |
$ -180 |
- |
Nanostring Technologies Inc |
$ 5 |
$ 162 |
$ -166 |
721 |
Fresh Tracks Therapeutics Inc |
$ 5 |
$ 10 |
$ -6 |
- |
Finch Therapeutics Group Inc |
$ 4 |
$ 1 |
$ -100 |
- |
Avalon Globocare Corp |
$ 4 |
$ 1 |
$ -9 |
- |
Qrons Inc |
$ 3 |
- |
$ -2 |
- |
Eloxx Pharmaceuticals Inc |
$ 3 |
- |
$ -32 |
- |
Aceragen Inc |
$ 3 |
- |
$ -41 |
- |
Palisade Bio Inc |
$ 3 |
- |
$ -13 |
- |
Peak Bio Inc |
$ 2 |
- |
$ -26 |
- |
Clarus Therapeutics Holdings Inc. |
$ 2 |
$ 8 |
$ -23 |
- |
Kiromic Biopharma Inc |
$ 2 |
- |
$ -23 |
- |
Windtree Therapeutics Inc |
$ 2 |
$ 1 |
$ -25 |
- |
Codiak Biosciences Inc |
$ 1 |
$ 34 |
$ -17 |
- |
Sqz Biotechnologies Company |
$ 1 |
- |
$ 0 |
- |
Polarityte Inc |
$ 1 |
$ 3 |
$ -8 |
- |
Tc Biopharm holdings Plc |
$ 1 |
$ 4 |
$ -1 |
- |
Ladrx Corporation |
$ 1 |
- |
$ 1 |
- |
Organicell Regenerative Medicine Inc |
$ 0 |
$ 5 |
$ -7 |
- |
Cannabis Global Inc. |
$ 0 |
$ 4 |
$ -4 |
- |
Genocea Biosciences Inc |
$ 0 |
$ 21 |
$ -37 |
- |
Point Of Care Nano technology Inc |
$ 0 |
- |
$ 0 |
- |
Spk Acquisition Corp |
- |
- |
$ -1 |
- |
Biontech Se |
- |
$ 540 |
$ 11,528 |
1,700 |
Coeptis Therapeutics Holdings Inc |
- |
- |
$ -57 |
- |
Anavex Life Sciences Corp |
- |
$ 3 |
$ -43 |
- |
Forma Therapeutics Holdings Inc. |
- |
- |
$ -190 |
- |
Agentix Corp |
- |
- |
$ -1 |
2 |
10x Capital Venture Acquisition Corp Iii |
- |
- |
$ -1 |
- |
Mosaic Immunoengineering Inc |
- |
- |
$ -1 |
- |
Biomx Inc |
- |
- |
$ 27 |
- |
Fennec Pharmaceuticals Inc |
- |
$ 13 |
$ -20 |
- |
Replicel Life Sciences Inc |
- |
- |
$ -1 |
- |
Calidi Biotherapeutics Inc |
- |
- |
$ -29 |
- |
Biondvax Pharmaceuticals Ltd |
- |
- |
$ -1 |
- |
Biotechnology & Pharmaceuticals Industry |
$ 558,836 |
$ 90,441 |
$ 3,925 |
76,397 |
Recent News from Biotechnology & Pharmaceuticals Industry |
Financing Agreement
Iselin-based biopharmaceutical company, Outlook Therapeutics, has successfully concluded its private placement, securing upfront gross proceeds of approximately $60 million. In addition, the company has the potential to further bolster its financial position with up to $99 million upon the exercise of warrants issued in the private placement. Th...
|
|
Cyclo Therapeutics Inc
Cyclo Therapeutics Inc, a Biotechnology and Pharmaceuticals company, has shown positive growth in the fourth quarter of 2023, despite industry-wide challenges. In its December 31, 2023 report, the company reported a significant revenue rise of 66.699% to $0.31 million. This increase in revenue has helped the company reduce its losses to $-0.18 per share, ...
|
|
Partnership
In a groundbreaking announcement, the McWhorter Family Trust has forged a strategic partnership with Bentley Motors, marking a significant milestone in the realm of automotive excellence. Recognizing Bentley's unrivaled dedication to luxury, innovation, and craftsmanship, the Trust has bestowed the prestigious emblem of automotive distinction upon the ren...
|
|
Product Service News
Scilex Holding Company Addresses Product Composition Questions for ELYXYB Patent in Canada, While Preparing for the Launch of Gloperba and Expanding Its Distribution NetworkPALO ALTO, Calif., March 18, 2024 ?? Scilex Holding Company (Nasdaq: SCLX), a revenue-generating company focused on non-opioid pain management products, has provided responses to Healt...
|
|
Clinical Study
Aligos Therapeutics, a prominent clinical stage biopharmaceutical company, has recently announced the initiation of the Phase 2a HERALD study of ALG-055009 in subjects with metabolic dysfunction-associated steatohepatitis (MASH). The study aims to address the unmet medical needs in liver and viral diseases and is a significant step for Aligos in developin...
|
|
Product Service News
Bluebird Bio Secures Debt Financing to Support Commercial Launches of Gene TherapiesBluebird Bio, a leading biotechnology company, has announced that it has secured a $175 million five-year term loan facility with Hercules Capital. This debt financing will strengthen the company's balance sheet as it focuses on the commercial launches of its three FDA-app...
|
|
Management Changes
In a strategic move to strengthen its position in the biotechnology industry, Ocugen Inc. (NASDAQ: OCGN) has recently appointed Dr. Huma Qamar as its new Chief Medical Officer (CMO). The addition of Dr. Qamar to the Ocugen team is expected to further accelerate the company's mission of discovering, developing, and commercializing innovative gene and ...
|
|
Calidi Biotherapeutics Inc
In the world of biotechnology and pharmaceuticals, Calidi Biotherapeutics Inc has recently announced its financial results for the fourth quarter of 2023. The company reported an operating deficit of $-18.246049 million, a significant increase from the operating deficit of $-2.714765 million in the fourth quarter of 2022. The net deficit for the finan...
|
|
Coherus Biosciences Inc
Coherus Biosciences, a leading biopharmaceutical company, has recently completed the divestiture of its Ophthalmology Franchise with an upfront cash payment of $170 million. This strategic move aims to strengthen the company's capital structure and focus on its core business areas. The divestiture of Coherus' Ophthalmology Franchise is a significant s...
|
|
Fresh Tracks Therapeutics Inc
Fresh Tracks Therapeutics Inc: Navigating Challenges and Charting a New Course As an investor and shareholder of Fresh Tracks Therapeutics Inc, I have closely followed the latest financial results and the recent announcement about the company's stock being suspended from trading on The Nasdaq Capital Market. As an avid reader of The , it is my pleasur...
|
|
|
|
|
|